SEC Form 4/A · accession 0001213900-26-068919
Unicycive Therapeutics, Inc. · UNCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Pramod Gupta
Officer — EVP, Pharmaceuticals and BD
Period of report
May 14, 2026
Accepted (ET)
Jun 15, 2026 · 5:24 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001766140
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | $0.00 | May 14, 2026 | A | 169,500 | A | — | — | Common Stock | 169,500 | 169,500 | D |
Explanation of responses
- F1Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. 23,542 shares vest upon grant and 4,708 shares vest monthly over 31 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer.